These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective. Niebel D; Novak N; Wilhelmi J; Ziob J; Wilsmann-Theis D; Bieber T; Wenzel J; Braegelmann C Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579181 [TBL] [Abstract][Full Text] [Related]
26. Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Rijkers GT; Weterings N; Obregon-Henao A; Lepolder M; Dutt TS; van Overveld FJ; Henao-Tamayo M Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34451973 [TBL] [Abstract][Full Text] [Related]
27. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. Barda N; Dagan N; Ben-Shlomo Y; Kepten E; Waxman J; Ohana R; Hernán MA; Lipsitch M; Kohane I; Netzer D; Reis BY; Balicer RD N Engl J Med; 2021 Sep; 385(12):1078-1090. PubMed ID: 34432976 [TBL] [Abstract][Full Text] [Related]
28. Changes in respiratory virus infection trends during the COVID-19 pandemic in South Korea: the effectiveness of public health measures. Park JY; Kim HI; Kim JH; Park S; Hwang YI; Jang SH; Kim YK; Jung KS Korean J Intern Med; 2021 Sep; 36(5):1157-1168. PubMed ID: 34399570 [TBL] [Abstract][Full Text] [Related]
29. COVID-19 vaccine-related interstitial lung disease: a case study. Park JY; Kim JH; Lee IJ; Kim HI; Park S; Hwang YI; Jang SH; Jung KS Thorax; 2022 Jan; 77(1):102-104. PubMed ID: 34362838 [No Abstract] [Full Text] [Related]
33. Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study. Huh K; Kim YE; Ji W; Kim DW; Lee EJ; Kim JH; Kang JM; Jung J Thorax; 2021 Sep; 76(9):939-941. PubMed ID: 33782081 [TBL] [Abstract][Full Text] [Related]
34. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases. Vojdani A; Vojdani E; Kharrazian D Front Immunol; 2020; 11():617089. PubMed ID: 33584709 [TBL] [Abstract][Full Text] [Related]
35. Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans. Cagigi A; Loré K Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33477534 [TBL] [Abstract][Full Text] [Related]
36. Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper From the Fleischner Society. Johkoh T; Lee KS; Nishino M; Travis WD; Ryu JH; Lee HY; Ryerson CJ; Franquet T; Bankier AA; Brown KK; Goo JM; Kauczor HU; Lynch DA; Nicholson AG; Richeldi L; Schaefer-Prokop CM; Verschakelen J; Raoof S; Rubin GD; Powell C; Inoue Y; Hatabu H Chest; 2021 Mar; 159(3):1107-1125. PubMed ID: 33450293 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Voysey M; Clemens SAC; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Collins AM; Colin-Jones R; Cutland CL; Darton TC; Dheda K; Duncan CJA; Emary KRW; Ewer KJ; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Goodman AL; Green CM; Green CA; Heath PT; Hill C; Hill H; Hirsch I; Hodgson SHC; Izu A; Jackson S; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Lawrie AM; Lelliott A; Libri V; Lillie PJ; Mallory R; Mendes AVA; Milan EP; Minassian AM; McGregor A; Morrison H; Mujadidi YF; Nana A; O'Reilly PJ; Padayachee SD; Pittella A; Plested E; Pollock KM; Ramasamy MN; Rhead S; Schwarzbold AV; Singh N; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Tarrant R; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; Watson MEE; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ; Lancet; 2021 Jan; 397(10269):99-111. PubMed ID: 33306989 [TBL] [Abstract][Full Text] [Related]